Drugs / Fu-zheng-qu-zhuo
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02275468 | Jun 2010 → May 2013 | chronic kidney disease | Guang'anmen Hospital of China Academy of Chinese Medical Sciences | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fu-zheng-qu-zhuo | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02275468 ↗ |
| Known as | FZQZ | “Fu-zheng-qu-zhuo (FZQZ) oral liquid” NCT02275468 ↗ |
| Route | Oral | “Fu-zheng-qu-zhuo (FZQZ) oral liquid” NCT02275468 ↗ |